MaxCyte, Inc. (MXCT) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc. (NASDAQ: MXCT) reported Q3 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $8 million versus the consensus estimate of $8.87 million.
For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sportradar Group AG (SRAD) Reports In-Line Q3 EPS ; Offers Guidance
- Rhythm Pharmaceuticals (RYTM) Tops Q3 EPS by 10c
- Sunoco LP (SUN) Misses Q3 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
